Indefinite Delivery Contract 75N92022D00016

Award Date 9/28/22
Last Date to Order 9/27/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health National Heart Lung and Blood Institute awarded Ovationio Inc. Barry Wark Division an indefinite delivery contract with a potential value of $47,970,000 to provide genotyping sequencing support. Under a firm fixed price delivery order valued at $7,307,586, Ovationio will genotype samples through April 2024 in Cambridge, Massachusetts to help track variations in viruses for the NIBIB Variant Task Force. The original pre-solicitation sought capability statements...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a single-award Indefinite Delivery Contract (IDC) to Illumina, Inc. worth up to $767,216.60 for the procurement of TAS::75 0888::TAS SY-401-1001 HISEQ 2000 products and services. The period of performance is from May 27, 2011 to May 29, 2012. Illumina, a for-profit manufacturer of genetic sequencing and genomic analysis instruments and reagents, has previously received prime...
The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...
Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH). The IDC has a ceiling value of $92,416,478 and a period of performance through March 2, 2026. Under this IDC and associated delivery orders, Illumina will provide a range of its advanced sequencing instruments,...
The Federal Supply Schedule contract No. 36F79722D0052 was awarded by the Department of Veterans Affairs (VA) to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory. This multiple-award contract, with a $40,000,000 ceiling value, authorizes VA facilities to procure a variety of medical laboratory testing and analysis services from Aegis' catalog of clinical pathology capabilities such as hematology, immunology, and microbiology tests. The contract has an...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
Genedx, LLC was awarded a single-award indefinite delivery contract by the Department of Health and Human Services' National Institutes of Health Clinical Center to provide mutation analysis services with a potential value of $1,012,384.00 and a period of performance through June 2024. Under this contract and associated task orders, Genedx will deliver specialized genetic and genomic testing services from its Maryland laboratory to support the NIH Clinical Center's clinical research mission....
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract with a potential value of $500 million to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract aims to support the Trans-Omics for Precision Medicine initiative through the provision of genomics data generation, analysis, and management services. Under the contract, the National...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services (HHS), has awarded a Blanket Purchase Agreement (BPA) to Eurofins Genomics LLC, a for-profit manufacturer of goods. The $10,000,000.00 BPA covers the delivery of biological materials, including custom oligonucleotides, DNA sequencing, and plasmid preparation services to support NINDS's biomedical research mission. The BPA has an ultimate completion date...
The National Institutes of Health National Institute on Aging awarded a single award indefinite delivery contract to Transnetyx, Inc., doing business as Harmonyx Diagnostics, with a potential value of $1,465,680. Task orders issued against the contract include $366,420 for genotyping services from April 2023 through April 2024, and $298,718 for similar services from May 2022 through April 2023. Both task orders are firm fixed price and will be performed in Cordova, Tennessee. The originating...
  • 75N92022D00016
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), has awarded Aegis Sciences Corporation a single-award, $47.97 million Indefinite Delivery Contract (IDC) to provide genotyping services for tracking viral variants. Task Order 001, valued at $17.77 million, has been issued under this IDC for genotyping services to be performed at Aegis' facility in Nashville, Tennessee from September 2022 to April 2024.

This contract was awarded following a sources sought notice issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Variant Task Force, seeking capability statements from qualified sources to potentially fulfill future sequencing support requirements. The sources sought notice did not use any set-asides. Aegis, a forensic toxicology and healthcare laboratory, was selected as the prime contractor based on its demonstrated expertise in providing COVID-19 testing, genomic sequencing, and variant tracking services to federal agencies like the NIH and Centers for Disease Control and Prevention.

Generated 7/18/24, 9:05 AM